SLRX   $1.56  -4.29% Market Closed

Salarius Pharmaceuticals Inc
Total Cash 3.27M
totalCashPerShare 2.271
EBITDA -6.73M
Total Debt 0.00
quickRatio 2.777
currentRatio 2.982
Total Revenue
debtToEquity
Revenue/Share
ROA -0.53991
ROE -1.1983
grossProfits
freeCashflow -6.13M
operatingCashflow -7.69M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.05M
forwardPE -0.16684842
floatShares 1.40M
sharesOutstanding 1.44M
sharesShort 1.53K
sharesShortPriorMonth 9.40K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders 0.03%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.0
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 3.705
Price To Book help_outline 0.41
earningsQuarterlyGrowth
netIncomeToCommon -6.46M
trailingEps -8.73%
forwardEps -9.17%
enterpriseToEbitda 0.16
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2024
institutionsCount 8
lastUpdated Nov. 6, 2024, 6:29 p.m.